Viorele Kit
Product Images NDC 68462-318

10 FDA label images from Glenmark Pharmaceuticals Inc., Usa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Viorele (NDC 68462-318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Image 09)

Figure (Image 09)
Chemical structure diagrams of Desogestrel, USP and Ethinyl Estradiol, USP. The left structure shows Desogestrel with a molecular formula of C22H30O, and the right structure displays Ethinyl Estradiol with a molecular formula of C20H24O2, illustrating the arrangement of carbon, hydrogen, and oxygen atoms in each molecule.*
FDA Label Image

Image02 (Image02)

Image02 (Image02)
A bar graph showing mortality rates (number of deaths per 100,000 woman-years) across four age groups (15-24, 25-34, 35-44, 45-). It compares four categories: ever-users (non-smokers), ever-users (smokers), controls (non-smokers), and controls (smokers), with varying mortality rates displayed for each age group and category.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A forest plot chart showing effect estimates with confidence intervals for various studies comparing hormonal contraceptive use (Ever COC vs. Never COC Use and Current COC use vs. Never-Use). The chart lists studies such as NICHD Women's Care Study, French E3N cohort, Shanghai Women's Health Study, and others along the y-axis, with effect estimates and confidence intervals plotted against a horizontal axis labeled 'Effect Estimate.' Odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals are shown in a box to the right.*
FDA Label Image

Logo1 (Logo1)

FDA Label Image

Image05 (Image05)

Image05 (Image05)
Diagram of a 28-pill pack kit for VIORELE showing the arrangement of white to off-white, light yellow to yellow, and pale green to yellowish green tablets. The diagram visually represents the weekly layout for taking the tablets, marked by days of the week and weeks, to guide proper usage within the pack.*
FDA Label Image

Image06 (Image06)

Image06 (Image06)
An instructional diagram showing a hand peeling and placing a day-of-week label on a 28-day oral contraceptive tablet blister pack. The blister pack is labeled with four weeks and seven pills per week, containing Desogestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.02 mg and Ethinyl Estradiol Tablets, USP 0.01 mg. The diagram demonstrates how to customize the pack with the correct day labels for daily pill tracking.*
FDA Label Image

Logo2 (Logo2)

FDA Label Image

Image03 (Image03)

Image03 (Image03)
Illustration labeled as an example of a 28-pill pack arranged in a weekly calendar format from Sunday to Saturday for four weeks. The diagram indicates the color coding of tablets: white to off-white for weeks 1 to 3, light yellow to yellow for the first tablet in week 4, and pale green to yellowish green for the remaining tablets in week 4. Tablet strengths for Desogestrel and Ethinyl Estradiol are noted as 0.15 mg/0.02 mg and Ethinyl Estradiol 0.01 mg on the diagram.*
FDA Label Image

Image04 (Image04)

Image04 (Image04)
An instructional diagram showing a hand placing a day label strip onto a weekly oral contraceptive tablet card. The card is organized into four rows labeled Week 1 to Week 4, with columns for each day of the week from Sunday to Saturday. The card contains round tablet slots labeled with the medication details: Desogestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.02 mg and Ethinyl Estradiol Tablets, USP 0.01 mg.*
FDA Label Image

Carton (Carton)

Carton (Carton)
Packaging label for VIORELE kit containing Desogestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.02 mg and Ethinyl Estradiol Tablets, USP 0.01 mg by Glenmark Pharmaceuticals Inc. The box indicates 3 blisters each with 28 tablets and includes storage instructions and manufacturer details. The label states Rx only and provides caution about medication safety and patient labeling.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.